NCT04163224 (RF-Advantage) is a clinical trial of RibFix Advantage in Rib Fracture Multiple, sponsored by Zimmer Biomet.

Who is sponsoring NCT04163224?

NCT04163224 is sponsored by Zimmer Biomet.

What drugs are being tested in NCT04163224?

Interventions in NCT04163224: RibFix Advantage.

What condition does NCT04163224 study?

NCT04163224 studies Rib Fracture Multiple.

Is NCT04163224 still recruiting?

NCT04163224 is currently withdrawn. Last updated 1 September 2020.

Last reviewed 2020-09-01 · How we verify

NCT04163224: RF-Advantage

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Minimal Invasive Approach for Surgical Repair of Rib Fractures With a Novel Intrathoracic Device

Withdrawn Last updated 1 September 2020

What this trial tests

trial testing RibFix Advantage in Rib Fracture Multiple. Withdrawn.

Timeline

1 April 2020

Primary endpoint
30 August 2020

30 December 2020

Quick facts

Lead sponsor	Zimmer Biomet
Status	Withdrawn
Study type	OBSERVATIONAL
Start date	1 April 2020
Primary completion	30 August 2020
Estimated completion	30 December 2020

Drugs / interventions tested

RibFix Advantage

Conditions studied

Rib Fracture Multiple — all drugs for Rib Fracture Multiple →

Sponsor

Zimmer Biomet — full company profile →

Who can join

18 and older, any sex, with Rib Fracture Multiple. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A retrospective review of demographics and adverse events from cases completed with the RibFix Advantage System. Evaluation of device integrity, and performance by a prospective CT scan with a minimum of 3 months post-implantation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of RibFix Advantage

Trials testing the same drug.

NCT05179005 — RibFix Advantage™ Post-Market Follow-Up · terminated

Other recruiting trials for Rib Fracture Multiple

Currently open trials in the same condition.

NCT06464302 — Investigation of the Effect of Age and Injury Severity on Short-term Intra-hospital Outcomes After Surgical Stabilized R · recruiting
NCT05748366 — Ultrasound Guided Serratus Anterior Plane Block for Rib Fractures · NA · recruiting

Other Zimmer Biomet trials

Trials by the same sponsor.

NCT06287853 — Tapestry Rotator Cuff Repair PMCF · suspended
NCT06863428 — Mymobility Knee ROM · recruiting
NCT06920459 — Zimmer Biomet Shoulder Arthroplasty PMCF Study · recruiting
NCT07009912 — ROSA® Knee System V1.5 Pilot Study · NA · completed
NCT06615739 — Comprehensive SRS Regenerex Tissue Attachment · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04163224 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Zimmer Biomet
Last refreshed: 1 September 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04163224.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing